Fig. 1From: Adjuvant intensity modulated whole-abdominal radiation therapy for high-risk patients with ovarian cancer FIGO stage III: final results of a prospective phase 2 studyLate toxicities of intensity modulated WART. Incidence of late toxicities according to Common Terminology Criteria for Adverse Events version 3.0. (Maximal Common Terminology Criteria for Adverse Events grade later than 6 weeks after end of WART)Back to article page